New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...

BiomX has dosed the first subject in the randomised Phase IIb trial of the company’s fixed multi-phage therapy, BX004, to ...

First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting ...

Removing incorrect penicillin allergy labels could improve care, reduce NHS costs and help tackle bacterial resistance, ...

A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and ...

EPHA4 pathway dysfunction causes axon pathfinding defects, resulting in impaired coordinated left-right locomotion by disrupting neural patterning and the function of central pattern generators, ...

Penicillins are first-choice antibiotics for many common infections, but more than one in 15 UK adults have a penicillin ...

Matthias Rillig’s research reveals a range of impacts of microplastics on soil-dwelling worms, bacteria, and plants—some of ...

Promega Plasmid Collection, available through Addgene, equips industry and academic researchers with powerful bioluminescent assays that provide deeper insights into endogenous cellular ...

A new study by scientists at the University of Colorado Anschutz Medical Campus reveals that joint tissue from patients with ...

Researchers at MIT and other institutions have identified compounds that can fight off viral infection by activating a ...

Researchers have identified that species in the gut microbiome can produce sphingolipids that protect the host from pathogens.